Effect of treatment modality and cerebral vasospasm agent on patient outcomes after aneurysmal subarachnoid hemorrhage in the elderly aged 75 years and older

We sought to examine whether the effect of treatment modality and drugs for cerebral vasospasm on clinical outcomes differs between elderly and non-elderly subarachnoid hemorrhage (SAH) patients in Japan. We analyzed the J-ASPECT Study Diagnosis Procedure Combination database (n = 17,343) that under...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2020-04, Vol.15 (4), p.e0230953-e0230953
Hauptverfasser:	Ido, Keisuke, Kurogi, Ryota, Kurogi, Ai, Nishimura, Kunihiro, Arimura, Koichi, Nishimura, Ataru, Ren, Nice, Kada, Akiko, Matsuo, Ryu, Onozuka, Daisuke, Hagihara, Akihito, Takagishi, So, Yamagami, Keitaro, Takegami, Misa, Nohara, Yasunobu, Nakashima, Naoki, Kamouchi, Masahiro, Date, Isao, Kitazono, Takanari, Iihara, Koji
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis Aneurysm Biology and Life Sciences Care and treatment Cilostazol Coiling Comorbidity Confidence intervals Edaravone Eicosapentaenoic acid Elderly patients Endovascular coiling Fatty acids Geriatrics Health services Hemorrhage Japan Medicine and Health Sciences Mortality Older people Omega 3 fatty acids Patient outcomes Patients People and Places Preventive medicine Sodium Statins Stroke Studies Subarachnoid hemorrhage Transient ischemic attack Unsaturated fatty acids Vasoconstriction
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!